Pharmacokinetics and pharmacodynamics of oral tolvaptan in patients with varying degrees of renal function
Author:
Publisher
Elsevier BV
Subject
Nephrology
Reference20 articles.
1. Oral tolvaptan is safe and effective in chronic hyponatremia;Berl;J Am Soc Nephrol,2010
2. Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia;Schrier;N Engl J Med,2006
3. Efficacy and safety of oral tolvaptan therapy in patients with the syndrome of inappropriate antidiuretic hormone secretion;Verbalis;Eur J Endocrinol,2011
4. Prescribing Information;Samsca (tolvaptan),2012
5. Tolvaptan in autosomal dominant polycystic kidney disease: three years’ experience;Higashihara;Clin J Am Soc Nephrol,2011
Cited by 35 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Efficacy and safety of tolvaptan in cirrhotic patients: a systematic review and meta-analysis of randomized controlled trials;Expert Review of Gastroenterology & Hepatology;2023-10-03
2. Identifying the main predictors of urine output in autosomal-dominant polycystic kidney disease (ADPKD) patients taking tolvaptan;International Urology and Nephrology;2023-03-23
3. Clinical Pattern of Tolvaptan-Associated Liver Injury in Trial Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD): An Analysis of Pivotal Clinical Trials;American Journal of Kidney Diseases;2023-03
4. Evaluation of Renal Impairment Influence on Metabolic Drug Clearance using a Modelling Approach;Clinical Pharmacokinetics;2023-01-11
5. Model-Based Comparative Analysis of Rifampicin and Rifabutin Drug-Drug Interaction Profile;Antimicrobial Agents and Chemotherapy;2021-08-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3